Concepedia

Adalimumab for induction of remission in Crohn's disease

Mohamad Abbass, Jeremy Cepek, Claire E. Parker, Tran M Nguyen, John K MacDonald, Brian G. Feagan, Reena Khanna, Vipul Jairath

Cochrane Database of Systematic Reviews · 2017 · 17 citations · 7 references

DOIFull text

Open access

Concepts

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The primary objective of this review is to assess the efficacy and safety of adalimumab for induction of remission in patients with active CD.

References

7

Bias in meta-analysis detected by a simple, graphical test

Matthias Egger, George Davey Smith, Martin Schneider et al. · BMJ · 1997 · 56.3K citations

, , +13

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Gordon Guyatt, Andrew D Oxman, Gunn Elisabeth Vist et al. · BMJ · 2008 · 22.1K citations · Full text

, , +8

Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

Stephen B. Hanauer, William J. Sandborn, Paul Rutgeerts et al. · Gastroenterology · 2006 · 1.7K citations

, , +13

Management of Crohn's Disease in Adults

Gary R Lichtenstein, Stephen B Hanauer, William J. Sandborn · The American Journal of Gastroenterology · 2009 · 1.2K citations

, , +8

Chapter 12: Interpreting results and drawing conclusions

Holger J. Schünemann, Andrew D Oxman, J Jonathan et al. · 2011 · 873 citations

, , +7